Most popular active substances contained in biosimilar drugs in Poland 2019
In the first half of 2019, most of the biosimilar drugs generating sales in Poland contained filgrastim, adalimumab, and infliximab.
Share of most popular acitve substances of biosimilar drugs sold in the total number of biosimilar drugs in Poland in 2019
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Pharmaceutical industry in Scandinavia
Pharmaceutical sales
8
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Value of pharmaceutical sales in Norway 2008-2022
- Basic Statistic Value of pharmaceutical sales in Sweden 2000-2022
- Basic Statistic Sales of pharmaceuticals in Norway 2020-2021, by prescription type
- Basic Statistic Revenue of pharmaceuticals in Sweden by type 2023
- Basic Statistic Revenue of most dispensed drugs at pharmacies in Denmark 2023
- Basic Statistic Sales volume pharmaceuticals in Norway by drug category 2022
- Basic Statistic Largest pharmaceutical classes in Sweden 2023, by sales value
Patents and clinical trials
6
- Basic Statistic Number of applications for clinical trials in Denmark 2013-2021, by sponsor
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021, by type of actor
- Basic Statistic Number of applications for clinical trials in Sweden 2014-2021, by sponsor
- Basic Statistic Number of biotechnology patents in Denmark 2011-2021
- Basic Statistic Number of biotechnology patents in Norway 2011-2021
- Basic Statistic Number of biotechnology patents in Sweden 2011-2021
Trade
5
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2023
- Basic Statistic Import and export value of basic pharmaceutical products in Norway 2009-2023
- Basic Statistic Net export value of pharmaceuticals from Sweden 2012-2022
- Basic Statistic Import value of pharmaceuticals into Sweden 2012-2022
- Basic Statistic Export value of pharmaceuticals from Sweden 2012-2022
Key players
6
Further related statistics
9
- Annual revenue of Shanghai Pharmaceuticals 2011-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
- Enterprise and brand value of Shoppers Drug Mart in 2012
Further Content: You might find this interesting as well
Statistics
- Annual revenue of Shanghai Pharmaceuticals 2011-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
- Enterprise and brand value of Shoppers Drug Mart in 2012
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
PMR. (June 12, 2020). Share of most popular acitve substances of biosimilar drugs sold in the total number of biosimilar drugs in Poland in 2019 [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1128566/poland-popular-active-substances-used-in-biosimilar-drugs/
PMR. "Share of most popular acitve substances of biosimilar drugs sold in the total number of biosimilar drugs in Poland in 2019." Chart. June 12, 2020. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1128566/poland-popular-active-substances-used-in-biosimilar-drugs/
PMR. (2020). Share of most popular acitve substances of biosimilar drugs sold in the total number of biosimilar drugs in Poland in 2019. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1128566/poland-popular-active-substances-used-in-biosimilar-drugs/
PMR. "Share of Most Popular Acitve Substances of Biosimilar Drugs Sold in The Total Number of Biosimilar Drugs in Poland in 2019." Statista, Statista Inc., 12 Jun 2020, https://www.statista.com/statistics/1128566/poland-popular-active-substances-used-in-biosimilar-drugs/
PMR, Share of most popular acitve substances of biosimilar drugs sold in the total number of biosimilar drugs in Poland in 2019 Statista, https://www.statista.com/statistics/1128566/poland-popular-active-substances-used-in-biosimilar-drugs/ (last visited December 21, 2024)
Share of most popular acitve substances of biosimilar drugs sold in the total number of biosimilar drugs in Poland in 2019 [Graph], PMR, June 12, 2020. [Online]. Available: https://www.statista.com/statistics/1128566/poland-popular-active-substances-used-in-biosimilar-drugs/